Completion of this activity will allow learners to discuss the mechanism of delivering radioactive drugs to the tumors based on the Theranostic Nuclear Medicine paradigm; discuss the current treatment options that work according to the Theranostic Nuclear Medicine paradigm; and discuss the optimal applications for Theranostic Nuclear Medicine in clinical practice. This activity is worth 0.75 AOA Category 1A / AMA Category 1 Credits.

Completion of this activity will allow learners to discuss and review the elements of the research enterprise and how it promotes disparities; identify what can be done to improve minorities and women participation in clinical research; and recognize the barrier to clinical research as it relates to ethnic minorities and women. This activity is worth 0.75 AOA Category 1A / AMA Category 1 Credits.

Completion of this activity will allow learners to develop a differential diagnosis of lymphadenopathy; Identify effective tools to assist in the diagnosis of lymphadenopathy; and explain general management strategies for patients with lymphadenopathy. This activity is worth 1.0 AOA Category 1A / AMA Category 1 Credits.

This activity will provide general internists and subspecialists with updates in clinical medicine, quality assurance and improvement, healthcare administration, and the integration of concepts from principle-centered medicine to outpatient and inpatient care. This activity is certified for 51.50 AOA Category 1A/AMA PRA Category 1 Credits.

Completion of this activity will allow learners to discuss medication and surgical errors, misdiagnoses and system failures; discuss creating a culture of safety, root cause analysis, error reduction and prevention, and patient safety; and review most common errors as defined by the FL-BOOM. This activity is worth 2.0 AOA Category 1A / AMA Category 1 Credits.